Delivery Order SPE2DB22D2009-SPE2DB25FM1DN
- Not listed
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,141.26. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,140.26 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. The contract carries a firm fixed price structure with no set-aside designation and is scheduled for ultimate completion by August 18, 2025. Performance will be executed from the contractor's facility located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.97 to AmerisourceBergen Drug Corp for Lisdexamfetamine 60 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,698.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count units) under a firm fixed price contract type. The award was issued on July 16, 2025, with an ultimate completion date of July 17, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,025.65 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). The contract was competitively awarded without set-aside provisions and is priced on a firm fixed-price basis, with an ultimate completion date of September 24, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1DNDelivery Order
The Defense Logistics Agency awarded a $1,644.04 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 30 mg capsules (100 count) with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems and other federal medical programs worldwide. The company's role as a critical pharmaceutical distributor enables the delivery of both brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency operations and broader federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/26/25 |